- Home
- AIZ vs LEGN Comparison
AIZ vs LEGN Comparison
Compare AIZ & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIZ
- LEGN
- Stock Information
- Founded
- AIZ 1892
- LEGN 2014
- Country
- AIZ United States
- LEGN United States
- Employees
- AIZ N/A
- LEGN N/A
- Industry
- AIZ Property-Casualty Insurers
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- AIZ Finance
- LEGN Health Care
- Exchange
- AIZ Nasdaq
- LEGN Nasdaq
- Market Cap
- AIZ 10.1B
- LEGN 5.4B
- IPO Year
- AIZ N/A
- LEGN 2020
- Fundamental
- Price
- AIZ $191.78
- LEGN $35.91
- Analyst Decision
- AIZ Strong Buy
- LEGN Strong Buy
- Analyst Count
- AIZ 6
- LEGN 13
- Target Price
- AIZ $231.33
- LEGN $75.17
- AVG Volume (30 Days)
- AIZ 403.1K
- LEGN 2.1M
- Earning Date
- AIZ 08-05-2025
- LEGN 08-08-2025
- Dividend Yield
- AIZ 1.68%
- LEGN N/A
- EPS Growth
- AIZ N/A
- LEGN N/A
- EPS
- AIZ 12.82
- LEGN N/A
- Revenue
- AIZ $12,071,400,000.00
- LEGN $728,303,000.00
- Revenue This Year
- AIZ $6.89
- LEGN $65.49
- Revenue Next Year
- AIZ $4.49
- LEGN $53.76
- P/E Ratio
- AIZ $14.90
- LEGN N/A
- Revenue Growth
- AIZ 6.18
- LEGN 112.46
- 52 Week Low
- AIZ $160.12
- LEGN $27.34
- 52 Week High
- AIZ $230.55
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- AIZ 40.22
- LEGN 59.23
- Support Level
- AIZ $193.94
- LEGN $32.42
- Resistance Level
- AIZ $200.11
- LEGN $36.91
- Average True Range (ATR)
- AIZ 3.73
- LEGN 1.54
- MACD
- AIZ -0.48
- LEGN 0.04
- Stochastic Oscillator
- AIZ 9.75
- LEGN 50.29
About AIZ Assurant Inc.
Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions (including extended service contracts, insurance policies and related services), extended service contracts and related services for consumer electronics and appliances, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. Key revenue is generated from Global Lifestyle segment.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.